Some lawmakers say no to drug advertising

Share this article:
Several lawmakers in Congress are calling on pharmaceutical companies to stop or at least tamp down their direct-to-consumer advertisements. The $4.3 billion ad sector is being cited as a contributor to high healthcare costs. Rep. James Moran (D-VA) said the ads violate decency standards. Rep. Henry Waxman (D-CA) said ads should not be shown right after receiving marketing approval from the government. Others say pharmaceutical companies should not be allowed to deduct advertising costs as a business expense. DTC was the second-biggest ad spender last year, according to Nielsen.
Share this article:

More in Products

FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management .Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

PDI introduces new swab

PDI introduces new swab

PDI has debuted the Prevantics® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to ...

Oregon Freeze Dry releases Easy Meal

Oregon Freeze Dry releases Easy Meal

A new brand from Oregon Freeze Dry is designed to help long-term care and other healthcare facilities prepare for a disaster.